Journal of Pineal Research

Papers
(The H4-Index of Journal of Pineal Research is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Melatonin Increased Autophagy Level to Facilitate Osteogenesis of Inflamed PDLSCs Through TMEM110 Signaling Pathways152
A phase II, single‐center, double‐blind, randomized placebo‐controlled trial to explore the efficacy and safety of intravenous melatonin in surgical patients with severe sepsis admitted to the intensi90
Correction to high sensitivity of melatonin suppression response to evening light in preschool‐aged children80
RETRACTION: Changes in the Expression of Melatonin Receptors Induced by Melatonin Treatment in Hepatocarcinoma HepG2 Cells74
Zygotic Exposure to Venlafaxine Disrupts the Circadian Locomotor Activity Behaviour in Zebrafish Larvae71
Transcriptomic and Metabolomic Signatures of Acute Circadian Misalignment in Mice70
BPS‐induced ovarian dysfunction: Protective actions of melatonin via modulation of SIRT‐1/Nrf2/NFĸB and IR/PI3K/pAkt/GLUT‐4 expressions in adult golden hamster61
Melatonin targets MoIcl1 and works synergistically with fungicide isoprothiolane in rice blast control56
Melatonin mediates reactive oxygen species homeostasis via SlCV to regulate leaf senescence in tomato plants54
Melatonin as a chronobiotic/cytoprotective agent in bone. Doses involved50
Therapeutic Potential of Melatonin in Gastrointestinal Cancers: Molecular Mechanisms, Preclinical Evidence and Clinical Implications47
Corrigendum to Melatonin Attenuates D‐Galactose‐Induced Memory Impairment, Neuroinflammation and Neurodegeneration via Rage/Nf‐ K B/Jnk Signaling Pat45
Microbial Melatonin Production Improves Plant Metabolic Function in Short‐Term Climate‐Induced Stresses43
Investigating the safety profiles of exogenous melatonin and associated adverse events: A pharmacovigilance study using WHO‐VigiBase42
From Seasonality to Species Conservation: Chronobiological Research on European Hamsters in Strasbourg, France42
Melatonin inhibits chondrosarcoma cell proliferation and metastasis by enhancing miR‐520f‐3p production and suppressing MMP7 expression42
Optimizing the Time and Dose of Melatonin as a Sleep‐Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose−Response Meta‐Analysis40
Issue Information40
Melatonin Ameliorates Atherosclerotic Plaque Vulnerability by Regulating PPARδ‐Associated Smooth Muscle Cell Phenotypic Switching39
37
Erratum to: Mitochondrial cytochrome P450 (CYP) 1B1 is responsible for melatonin‐induced apoptosis in neural cancer cells37
Issue Information36
Light‐Dependent Circadian Rhythm Governs O‐GlcNAc Cycling to Influence Cognitive Function in Adult Zebrafish36
Anti‐PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model35
Exogenous Melatonin Regulates Hormone Signalling and Photosynthesis‐Related Genes to Enhance Brassica napus. Yield: A Transcriptomic Perspective34
Melatonin Enhances Peanut Productivity by Enriching Root‐Associated Nitrogen‐Fixing Bacteria34
Relationship Between Urinary 6‐Sulfatoxymelatonin Rhythms and the Bone Resorption Marker Amino‐Terminal Cross‐Linked Telopeptide of Collagen I in Blind Women33
3‐Month Melatonin Supplementation to Reduce Brain Oxidative Stress and Improve Sleep in Mild Cognitive Impairment: A Randomised Controlled Feasibility Trial32
31
From gestational chronodisruption to noncommunicable diseases: Pathophysiological mechanisms of programming of adult diseases, and the potential therapeutic role of melatonin31
Effect of melatonin cream on acute radiation dermatitis in patients with primary breast cancer: A double‐blind, randomized, placebo‐controlled trial30
RETRACTION: Melatonin Inhibits the Expression of the Inducible Isoform of Nitric Oxide Synthase and Nuclear Factor Kappa B Activation in Rat Skeletal Muscle30
RETRACTION: Melatonin Suppresses Proinflammatory Mediators in Lipopolysaccharide‐Stimulated CRL1999 Cells via Targeting MAPK, NF‐κB, c/EBPβ, and p300 Signaling30
0.24231100082397